Loader

Pathways

PathWhiz ID Pathway Meta Data

PW144360

Pw144360 View Pathway
drug action

Pregabalin Drug Metabolism Action Pathway

Homo sapiens

PW145517

Pw145517 View Pathway
drug action

Pregnenolone Drug Metabolism Action Pathway

Homo sapiens

PW145581

Pw145581 View Pathway
drug action

Prenylamine Drug Metabolism Action Pathway

Homo sapiens

PW123412

Pw123412 View Pathway
metabolic

PreQ0 Metabolism

Pseudomonas aeruginosa
PreQ0 or 7-cyano-7-carbaguanine is biosynthesized by degrading GTP. GTP first interacts with water through a GTP cyclohydrolase resulting in the release of a formate, a hydrogen ion and a 7,8-dihydroneopterin 3'-triphosphate. The latter compound then interacts with water through a 6-carboxy-5,6,7,8-tetrahydropterin synthase resulting in a acetaldehyde, triphosphate, 2 hydrogen ion and 6-carboxy-5,6,7,8-tetrahydropterin. The latter compound then reacts spontaneously with a hydrogen ion resulting in the release of a ammonium molecule and a 7-carboxy-7-deazaguanine. This compound then interacts with ATP and ammonium through 7-cyano-7-deazaguanine synthase resulting in the release of water, phosphate, ADP, hydrogen ion and a 7-cyano-7-carbaguanine. The degradation of 7-cyano-7-deazaguanine can lead to produce a preQ1 or a queuine by reacting with 3 hydrogen ions and 2 NADPH through a 7-cyano-7-deazaguanine reductase. PreQ1 then interacts with a guanine 34 in tRNA through a tRNA-guanine transglycosylase resulting in a release of a guanine and a 7-aminomethyl-7-deazaguanosine 34 in tRNA. This nucleic acid then interacts with SAM through a S-adenosylmethionine tRNA ribosyltransferase-isomerase resulting in a release of a hydrogen ion, L-methionine, adenine and an epoxyqueuosine

PW001893

Pw001893 View Pathway
metabolic

PreQ0 Metabolism

Escherichia coli
PreQ0 or 7-cyano-7-carbaguanine is biosynthesized by degrading GTP. GTP first interacts with water through a GTP cyclohydrolase resulting in the release of a formate, a hydrogen ion and a 7,8-dihydroneopterin 3'-triphosphate. The latter compound then interacts with water through a 6-carboxy-5,6,7,8-tetrahydropterin synthase resulting in a acetaldehyde, triphosphate, 2 hydrogen ion and 6-carboxy-5,6,7,8-tetrahydropterin. The latter compound then reacts spontaneously with a hydrogen ion resulting in the release of a ammonium molecule and a 7-carboxy-7-deazaguanine. This compound then interacts with ATP and ammonium through 7-cyano-7-deazaguanine synthase resulting in the release of water, phosphate, ADP, hydrogen ion and a 7-cyano-7-carbaguanine. The degradation of 7-cyano-7-deazaguanine can lead to produce a preQ1 or a queuine by reacting with 3 hydrogen ions and 2 NADPH through a 7-cyano-7-deazaguanine reductase. PreQ1 then interacts with a guanine 34 in tRNA through a tRNA-guanine transglycosylase resulting in a release of a guanine and a 7-aminomethyl-7-deazaguanosine 34 in tRNA. This nucleic acid then interacts with SAM through a S-adenosylmethionine tRNA ribosyltransferase-isomerase resulting in a release of a hydrogen ion, L-methionine, adenine and an epoxyqueuosine

PW145630

Pw145630 View Pathway
drug action

Pretomanid Drug Metabolism Action Pathway

Homo sapiens

PW176354

Pw176354 View Pathway
metabolic

Pretomanid Predicted Metabolism Pathway

Homo sapiens
Metabolites of sildenafil are predicted with biotransformer.

PW126541

Pw126541 View Pathway
drug action

Prilocaine

Homo sapiens
Prilocaine is an local anesthetic that is similar to lidocaine often used most commonly for dental procedures. Prilocaine acts by binding to the intracellular surface of the sodium channels which blocks the influx of sodium into the cell. Due to this block of sodium ions this prevents the generation and propagation of action potential. This reverses when the drug diffuses out of the cell and is excreted from the body, allowing the sodium channel to function as it normally would and continue to generate action potential. Prilocaine is metabolized by the liver and kidney and is excreted by the kidney.

PW000407

Pw000407 View Pathway
drug action

Prilocaine Action Pathway

Homo sapiens
Prilocaine exerts its local anaesthetic effect by blocking voltage-gated sodium channels in peripheral neurons. Prilocaine diffuses across the neuronal plasma membrane in its uncharged base form. Once inside the cytoplasm, it is protonated and this protonated form enters and blocks the pore of the voltage-gated sodium channel from the cytoplasmic side. For this to happen, the sodium channel must first become active so that so that gating mechanism is in the open state. Therefore prilocaine preferentially inhibits neurons that are actively firing.

PW144861

Pw144861 View Pathway
drug action

Prilocaine Drug Metabolism Action Pathway

Homo sapiens